[1] Hernandez-Prera JC, Skálová A, Franchi A, et al. Pleomorphic adenoma: The great mimicker of malignancy[J]. Histopathology, 2021, 79(3): 279-290.
[2] Vašková J, Kočan L, Vaško L, et al. Glutathione-related enzymes and proteins: A review[J]. Molecules, 2023, 28(3): 1447.
[3] 纪林冬, 姜宝飞. GPX3 的转录表达作为胃癌患者生存的预后标志物 [J]. 现代消化及介入诊疗, 2023, 28(3): 305-310, 316.
[4] 陈辉, 茅建娅, 马震, 等. Gal-1、GPX3 及 Tg 水平与甲状腺癌病情严重程度的关系分析 [J]. 实用癌症杂志, 2022, 37(8): 1276-1279.
[5] 丰露露. GPX3 对结肠癌的诊断和预后判断的临床价值 [D]. 合肥 : 安徽医科大学, 2023.
[6] 胡云龙, 白盼盼, 张美英, 等. GPX3 基因甲基化是胰腺癌的潜在诊断标志物 [J]. 胃肠病学和肝病学杂志, 2022, 31(5): 558-562.
[7] 宋敏, 李咏, 王亚楠, 等. GPX3 DNA 甲基化在恶性肿瘤发生发展中作用的研究进展 [J]. 现代肿瘤医学, 2022, 30(1): 167-171.
[8] 李茜 . 上消化道肿瘤高发区胃癌相关危险因素及 GPX3基因甲基化的研究 [D]. 天津: 天津医科大学, 2019.
[9] Zhou C, Hu HC, Zheng ZH, et al. Association between GPX3 promoter methylation and malignant tumors: A meta-analysis[J]. Pathol Res Pract, 2019, 215(7): 152443.
[10] Usman S, Ahmed S, Iqbal S, et al. Pleomorphic adenoma of minor salivary gland[J]. J Coll Physicians Surg Pak, 2022, 32(4): S70-S72.
[11] Chang C, Worley BL, Phaëton R, et al. Extracellular glutathione peroxidase GPx3 and its role in cancer[J]. Cancers, 2020, 12(8): 2197.
[12] Nirgude S, Choudhary B. Insights into the role of GPX3, a highly efficient plasma antioxidant, in cancer[J]. Biochem Pharmacol, 2021, 184: 114365.
[13] Lou WY, Ding BS, Wang SQ, et al. Overexpression of GPX3, a potential biomarker for diagnosis and prognosis of breast cancer, inhibits progression of breast cancer cells in vitro[J]. Cancer Cell Int, 2020, 20: 378.
[14] Cai MJ, Sikong YH, Wang Q, et al. Gpx3 prevents migration and invasion in gastric cancer by targeting NFкB/Wnt5a/JNK signaling[J]. Int J Clin Exp Pathol, 2019, 12(4): 1194-1203.
[15] 张帆. GPX3 在腮腺多形性腺瘤中的表达及意义 [D]. 乌鲁木齐 : 新疆医科大学, 2020.
[16] 于成龙, 李冀, 冯莹, 等. 谷胱甘肽过氧化物酶 3 与肿瘤 [J]. 诊断病理学杂志, 2021, 28(6): 493-496.
[17] Salta S, Macedo-Silva C, Miranda-Gonçalves V, et al. A DNA methylation-based test for esophageal cancer detection[J]. Biomark Res, 2020, 8(1): 68.
[18] Zhou C, Pan RR, Li B, et al. GPX3 hypermethylation in gastric cancer and its prognostic value in patients aged over 60[J]. Future Oncol, 2019, 15(11): 1279-1289.
[19] Lin YB, Zhang Y, Chen YL, et al. Promoter methylation and clinical significance of GPX3 in esophageal squamous cell carcinoma[J]. Pathol Res Pract, 2019, 215(11): 152676.
[20] Southekal S, Shakyawar SK, Bajpai P, et al. Molecular subtyping and survival analysis of osteosarcoma reveals prognostic biomarkers and key canonical pathways[J]. Cancers, 2023, 15(7): 2134.
|